Waters Stock Price, News & Analysis

Waters Corporation (NYSE:WAT) has launched the TRIOS AutoPilot software, enhancing its thermal analyzer product line under the TA Instruments Division. This software allows laboratory staff to develop standard operating procedures (SOPs) up to 25% faster and eliminates transcription errors, improving productivity and consistency in thermal analysis. It utilizes Google’s Blockly interface, making it user-friendly for script creation without advanced programming skills. The TRIOS AutoPilot includes built-in compliance features, ensuring regulatory adherence, and is available globally.

Waters Corporation (NYSE:WAT) has expanded its collaboration with Singapore's Bioprocessing Technology Institute (BTI) to enhance analytics in glycomics and metabolomics. The partnership aims to improve the rapid identification of complex biomolecules that are crucial for biologics manufacturing. Utilizing advanced instruments like the SYNAPT™ mass spectrometry system, the project addresses the challenges of characterizing biopharmaceuticals through data analytics and machine learning. This collaboration builds on a successful relationship since 2014, targeting cost reduction and efficiency in biomanufacturing processes.

Waters Corporation (NYSE: WAT) has appointed Wei Jiang to its Board of Directors, effective July 14, 2021. Wei currently serves as Executive Vice President at Bayer Pharmaceuticals for the China and APAC regions. His expertise in driving results in fast-growing markets, particularly in China, is viewed as a significant asset for Waters. Dr. Udit Batra, CEO, notes that Wei's experience aligns with the company's growth strategy in the pharmaceutical sector. Wei expressed enthusiasm about contributing to Waters' ongoing transformation, highlighting growth potential in China's pharma market.

Waters Corporation (NYSE:WAT) has launched the Waters Arc Premier System, the first liquid chromatography system designed for 2.5 – 3.5 micron columns featuring MaxPeak High Performance Surface (HPS) technology. This system reduces analyte-surface interactions, thereby improving analytical results for laboratories. Benefits include increased sensitivity, reproducibility, and potential savings of 2-3 days per assay by eliminating passivation. The combination of the Arc Premier System and MaxPeak Premier Columns aims to enhance productivity, accuracy, and confidence in pharmaceutical analysis.

Waters Corporation (NYSE:WAT) has launched the Waters™ SELECT SERIES™ MRT, an advanced mass spectrometer integrating Multi Reflecting Time-of-Flight (MRT) technology with enhanced DESI and new MALDI imaging sources. This device allows for rapid, precise identification of molecules, achieving speeds of up to 10Hz without losing mass accuracy. The SELECT SERIES MRT boasts a resolution of 200,000 FWHM, setting a new standard in mass spectrometry. Shipments are slated to begin in Q4 of this year, promising significant advancements in biological research and imaging applications.

Waters Corporation (NYSE:WAT) has launched a new RUO LC-MS test method, the SARS-CoV-2 LC-MS Kit, to enhance infectious disease research. This innovative method allows for the direct detection and quantification of SARS-CoV-2 Nucleocapsid (NCAP) peptides, yielding highly accurate results. Developed in collaboration with various research entities, this method aims to support high-throughput screening with reduced reliance on PCR reagents. The kit can quantify low levels of NCAP peptides, facilitating impactful studies on infection stages and future pandemic preparedness.

Waters Corporation (NYSE: WAT) reported first quarter 2021 sales of $609 million, up 31% from $465 million in Q1 2020. EPS rose to $2.37 (GAAP) from $0.86 yoy. Net cash from operations reached $218 million, an increase from $152 million. Instrument sales grew 49%, with pharmaceutical sales up 32%. The company anticipates full-year 2021 constant-currency sales growth of 8% to 11% and non-GAAP EPS of $9.85 to $10.05. The Q1 earnings call is scheduled for May 5, 2021.

Waters Corporation (NYSE:WAT) will present at the Bank of America Securities 2021 Virtual Health Care Conference on May 12, 2021, at 2:00 PM EST. CEO Udit Batra will address the investment community, discussing the company’s innovations in chromatography and mass spectrometry that have served the life sciences for over 60 years. Waters, a leader in specialty measurement, has a global workforce of 7,400 and operates in 35 countries.